Close Menu

NEW YORK (GenomeWeb) – Finnish firm Mobidiag has secured funding to develop a rapid molecular sepsis assay on its Novodiag system. The new funding consists of a €1.5 million ($1.74 million) loan for the first year of the project supplied by Business Finland, a funding agency formerly known as Tekes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.